Precancer Molecular Diagnostics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Precancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precancer Molecular Diagnostics Overall Market Size
2.1 Global Precancer Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Precancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precancer Molecular Diagnostics Players in Global Market
3.2 Top Global Precancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Precancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Precancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Precancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Precancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Precancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Precancer Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Precancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Precancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Precancer Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precancer Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Precancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Precancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Precancer Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Precancer Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Precancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Precancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Precancer Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Precancer Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Precancer Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Precancer Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Precancer Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Precancer Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Precancer Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Precancer Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Precancer Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Precancer Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Precancer Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Precancer Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Precancer Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Precancer Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Precancer Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Precancer Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precancer Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Precancer Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Precancer Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Precancer Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Precancer Molecular Diagnostics Market Size, 2018-2030
7 Precancer Molecular Diagnostics Companies Profiles
7.1 Genetronhealth
7.1.1 Genetronhealth Company Summary
7.1.2 Genetronhealth Business Overview
7.1.3 Genetronhealth Precancer Molecular Diagnostics Major Product Offerings
7.1.4 Genetronhealth Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Genetronhealth Key News & Latest Developments
7.2 Sanvalley
7.2.1 Sanvalley Company Summary
7.2.2 Sanvalley Business Overview
7.2.3 Sanvalley Precancer Molecular Diagnostics Major Product Offerings
7.2.4 Sanvalley Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Sanvalley Key News & Latest Developments
7.3 Premed
7.3.1 Premed Company Summary
7.3.2 Premed Business Overview
7.3.3 Premed Precancer Molecular Diagnostics Major Product Offerings
7.3.4 Premed Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Premed Key News & Latest Developments
7.4 Gene+
7.4.1 Gene+ Company Summary
7.4.2 Gene+ Business Overview
7.4.3 Gene+ Precancer Molecular Diagnostics Major Product Offerings
7.4.4 Gene+ Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Gene+ Key News & Latest Developments
7.5 Annoroad
7.5.1 Annoroad Company Summary
7.5.2 Annoroad Business Overview
7.5.3 Annoroad Precancer Molecular Diagnostics Major Product Offerings
7.5.4 Annoroad Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Annoroad Key News & Latest Developments
7.6 Topgen
7.6.1 Topgen Company Summary
7.6.2 Topgen Business Overview
7.6.3 Topgen Precancer Molecular Diagnostics Major Product Offerings
7.6.4 Topgen Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Topgen Key News & Latest Developments
7.7 Anpac
7.7.1 Anpac Company Summary
7.7.2 Anpac Business Overview
7.7.3 Anpac Precancer Molecular Diagnostics Major Product Offerings
7.7.4 Anpac Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Anpac Key News & Latest Developments
7.8 Kingmed
7.8.1 Kingmed Company Summary
7.8.2 Kingmed Business Overview
7.8.3 Kingmed Precancer Molecular Diagnostics Major Product Offerings
7.8.4 Kingmed Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Kingmed Key News & Latest Developments
7.9 Unitedgene
7.9.1 Unitedgene Company Summary
7.9.2 Unitedgene Business Overview
7.9.3 Unitedgene Precancer Molecular Diagnostics Major Product Offerings
7.9.4 Unitedgene Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Unitedgene Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Precancer Molecular Diagnostics Major Product Offerings
7.10.4 Roche Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
7.11 Foundationmedicine
7.11.1 Foundationmedicine Company Summary
7.11.2 Foundationmedicine Business Overview
7.11.3 Foundationmedicine Precancer Molecular Diagnostics Major Product Offerings
7.11.4 Foundationmedicine Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Foundationmedicine Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Precancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Precancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Precancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Precancer Molecular Diagnostics in Global Market
Table 5. Top Precancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Precancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Precancer Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Precancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Precancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Precancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Precancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Precancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Precancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Precancer Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Precancer Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Genetronhealth Company Summary
Table 31. Genetronhealth Precancer Molecular Diagnostics Product Offerings
Table 32. Genetronhealth Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Genetronhealth Key News & Latest Developments
Table 34. Sanvalley Company Summary
Table 35. Sanvalley Precancer Molecular Diagnostics Product Offerings
Table 36. Sanvalley Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Sanvalley Key News & Latest Developments
Table 38. Premed Company Summary
Table 39. Premed Precancer Molecular Diagnostics Product Offerings
Table 40. Premed Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Premed Key News & Latest Developments
Table 42. Gene+ Company Summary
Table 43. Gene+ Precancer Molecular Diagnostics Product Offerings
Table 44. Gene+ Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Gene+ Key News & Latest Developments
Table 46. Annoroad Company Summary
Table 47. Annoroad Precancer Molecular Diagnostics Product Offerings
Table 48. Annoroad Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Annoroad Key News & Latest Developments
Table 50. Topgen Company Summary
Table 51. Topgen Precancer Molecular Diagnostics Product Offerings
Table 52. Topgen Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Topgen Key News & Latest Developments
Table 54. Anpac Company Summary
Table 55. Anpac Precancer Molecular Diagnostics Product Offerings
Table 56. Anpac Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Anpac Key News & Latest Developments
Table 58. Kingmed Company Summary
Table 59. Kingmed Precancer Molecular Diagnostics Product Offerings
Table 60. Kingmed Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Kingmed Key News & Latest Developments
Table 62. Unitedgene Company Summary
Table 63. Unitedgene Precancer Molecular Diagnostics Product Offerings
Table 64. Unitedgene Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Unitedgene Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Precancer Molecular Diagnostics Product Offerings
Table 68. Roche Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. Foundationmedicine Company Summary
Table 71. Foundationmedicine Precancer Molecular Diagnostics Product Offerings
Table 72. Foundationmedicine Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Foundationmedicine Key News & Latest Developments
List of Figures
Figure 1. Precancer Molecular Diagnostics Segment by Type in 2022
Figure 2. Precancer Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Precancer Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Precancer Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Precancer Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precancer Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Genetronhealth Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanvalley Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Premed Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gene+ Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Annoroad Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Topgen Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Anpac Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kingmed Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Unitedgene Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Foundationmedicine Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
